Industry

Mr. Nunn will add unparalleled pharmaceutical industry insights for Humanetics, which is advancing its lead drug candidate BIO 300 through clinical trials MINNEAPOLIS–(BUSINESS WIRE)–Humanetics Corporation (Humanetics), a clinical-stage specialty pharmaceutical company pioneering radiation countermeasures, adjunctive oncology therapies, and pulmonary protective therapies for COVID-19, has announced the addition of renowned venture capitalist and life science industry … [Read more…]

CHICAGO–(BUSINESS WIRE)–The demands of examinations for independent testing institutes and labs have been expanding and growing from the continuous impact of the pandemic. Taiwan Excellence is leading a team of award-winning medical testing products to attend the largest and most influential global expo, AACC in Chicago, aiming for post-pandemic business opportunities. Many countries have been … [Read more…]

SOMERSET, N.J.–(BUSINESS WIRE)–Catalent, Inc. (NYSE: CTLT), the global leader in enabling biopharma, cell, gene, and consumer health partners to optimize development, launch, and supply of better patient treatments across multiple modalities, today announced that it has reached an agreement to acquire Metrics Contract Services (Metrics), a full-service specialty Contract Development and Manufacturing Organization (CDMO) with … [Read more…]

— FDA Cleared IND Application for STAR-0215 for the Treatment of Hereditary Angioedema — — Phase 1a Clinical Trial of STAR-0215 in Healthy Subjects Initiated, Preliminary Results Anticipated by Year-End 2022 — — Company to Host a Virtual R&D Day on September 30 — BOSTON–(BUSINESS WIRE)–Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company developing STAR-0215 for … [Read more…]

Strong second quarter sales of $2.2 billion, up 5%, or 10% constant currency (cc) Second quarter earnings of $0.30 per diluted share, down 3%, or up 34% cc Second quarter core earnings of $0.63 per diluted share, up 13%, or 30% cc Updated 2022 full year outlook reflects strong underlying operational performance, impacted by strength … [Read more…]

Strong second quarter sales of $2.2 billion, up 5%, or 10% constant currency (cc) Second quarter earnings of $0.30 per diluted share, down 3%, or up 34% cc Second quarter core earnings of $0.63 per diluted share, up 13%, or 30% cc Updated 2022 full year outlook reflects strong underlying operational performance, impacted by strength … [Read more…]

Innovative integrated service model will strengthen supply chain resiliency throughout Allina Health’s hospital and clinical care network, improving care delivery for providers and patients Partnership leverages Owens & Minor expertise, technology and solutions to create a unique, customized supply chain solution with greater visibility, transparency and control for Allina Health MINNEAPOLIS & RICHMOND, Va.–(BUSINESS WIRE)–Owens … [Read more…]

NEW BRUNSWICK, N.J.–(BUSINESS WIRE)–Johnson & Johnson (NYSE: JNJ) will participate in the Morgan Stanley 20th Annual Global Healthcare Conference on Wednesday, September 14th, at the Sheraton New York Hotel in New York. Joaquin Duato, Chief Executive Officer, and Joseph J. Wolk, Executive Vice President and Chief Financial Officer will represent the Company in a session … [Read more…]

New ARCT-154 clinical booster data demonstrate promising durability; 44- and 39-fold increases in neutralizing antibody response against Omicron BA.1 and BA.2 at Day 91 New cold chain data for Arcturus’ lyophilized vaccine platform shows favorable stability, shipping, and storage advantages European Commission grants Orphan Medicinal Product Designation to ARCT-810, a novel mRNA candidate for ornithine … [Read more…]

ROCKVILLE, Md.–(BUSINESS WIRE)–BioMarker Strategies today announced that the journal CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS has published a manuscript by the Company’s scientists entitled “Functional Profiling of Head and Neck/Esophageal Squamous Cell Carcinoma to Predict Cetuximab Response”. The manuscript describes the company’s progress in identifying predictive dynamic biomarkers to help identify the subset of patients with head … [Read more…]